+44 7868 792050
Executive Director, Pharmalytik LLC
Kim Huynh-Ba is the Executive Director and CEO of Pharmalytik LLC, where she provides advices and training services to pharmaceutical companies. She has over 25 years of experience in analytical development, strategic drug development, quality systems and stability sciences. Prior to Pharmalytik, she was the Director of the USP Pharmacopeial Education Department, where she was responsible for their education programs worldwide. She has authored and co-authored numerous publications and is the editor of two book volumes, “Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies and Best Practices” and “Pharmaceutical Stability Testing to Support Global Markets”. Kim is a member of the US Pharmacopeia's Council of Experts for the 2015-2020 cycle and is the Chair the Chemical Medicines IV Expert Committee. She is also the Chair of USP Good Documentation Practices Expert Panel and a member of USP Impurities of Drug Products Expert Panel and the Food Adulteration Expert Panel. Kim is a member of the Governing Board of Eastern Analytical Symposium (EAS) and was their 2013 President. She is an Adjunct Professor at Temple University-School of Pharmacy, Widener University and Illinois Institute of Technology (IIT) teaching pharmaceutical analysis, quality audit and GMPs graduate courses. Kim is also a short course instructor on numerous cGMP compliance and quality topics for several global organizations such as American Chemical Society (ACS), American Association of Pharmaceutical Scientists (AAPS), Pittsburgh Conference, and many other international training groups, She completed her undergraduate work in Chemistry and Mathematics at Millersville University, Pennsylvania, USA and her graduate work in Analytical Chemistry at Villanova University, Villanova, USA.
Lean Strategies, GMPs and Quality Systems, Stability Sciences, Life Cycle Management of Drug Development, Food Adulteration Detection.